• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Array BioPharma, Inc. (ARRY)

    -NasdaqGM
    4.80 0.09(1.91%) Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:4.71
    Open:4.79
    Bid:4.78 x 300
    Ask:4.84 x 500
    1y Target Est:7.57
    Beta:3.13
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:4.70 - 4.81
    52wk Range:2.98 - 5.64
    Volume:1,285,112
    Avg Vol (3m):1,999,310
    Market Cap:633.42M
    P/E (ttm):N/A
    EPS (ttm):-0.77
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARRYUp 1.91%633.42M
    ARQL75.32M
    BMY100.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):18.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.72
    Quarterly EPS Est (Dec-14) :-0.20
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-0.64

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback